Fibrocell Science

Today we announced that Fibrocell has officially been acquired by Castle Creek Pharmaceuticals to become one company focused on delivering new therapies for patient communities with high unmet need. See our press release

Castle Creek Pharmaceutical Holdings Completes Acquisition of Fibrocell Science - Acquisition complements and expands Castle Creek clinical development pipeline to include gene therapy platform - - Strategic acquisition to result in advancement of multiple late-stage investigational therapies for epidermolysis bullosa and other rare conditions – Exton, PA., December 16, 2019 ...

Honored to support the Rare Disease Legislative Advocates’ 8th Annual RareVoice Awards tonight in Washington, DC. This event recognizes & celebrates the tireless work of advocates in rare disease communities across the country. RDLA is a program of the EveryLife Foundation for Rare Diseases.

RareVoice Awards - Rare Disease Legislative Advocates The RareVoice Awards is an annual celebration to honor advocates who give rare disease patients a voice on Capitol Hill and in state government. Patient advocates, industry executives, and Congressional and government agency staff gather to honor these outstanding advocates in the rare disease commu...

Congratulations to debra of America for presenting the inspiring & memorable 21st Annual debra Benefit that honors, celebrates, and provides support to the Epidermolysis Bullosa community. We Fight EB!!